We invite you to an insights-driven exploration of Covid-driven changes occurring in HCPs’ prescribing decisions, virtual patient visits, and rep e-details. Understanding the specific reasons for these behavioral changes will help your team move towards restart, as we begin to reopen across the country post-Covid.
Join our May 14 complimentary webinar to gain early insights on the impact of Covid-19 on HCP practices and the resulting new era of HCP engagement. Ipsos’ experts will review the second-wave results of our Covid-19 HCP Surveillance Research with 398 HCPs across nine specialties, conducted together with M360 Research. Together we will explore how Covid-19 is changing HCPs’ practice dynamics and their interactions with pharmaceutical manufacturers.
During this webinar, we will:
- Explore the implications and opportunities for brand planning
- Break down potential barriers to your field force strategy
- Help you assess appropriate action, when adapting to this new normal
Don’t miss your opportunity to glean insights from Ipsos’ data and the discussion with our experts during our interactive audience Q&A.
If you can’t attend live, please register to receive the recording.
Scott Morano, Vice President, Ipsos
D’Arcy King, Senior Vice President, Ipsos